CID 71269142

Gusacitinib

Structural Information

Molecular Formula
C24H28N8O2
SMILES
C1CN(CCC1CC#N)C2=NC3=C(C(=O)NN=C3)C(=N2)NC4=CC=C(C=C4)N5CCC(CC5)O
InChI
InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29)
InChIKey
NLFLXLJXEIUQDL-UHFFFAOYSA-N
Compound name
2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

8
References

573
Patents

460.23352 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 461.24080 219.9
[M+Na]+ 483.22274 232.1
[M+NH4]+ 478.26734 220.7
[M+K]+ 499.19668 221.6
[M-H]- 459.22624 216.8
[M+Na-2H]- 481.20819 222.3
[M]+ 460.23297 219.7
[M]- 460.23407 219.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe